Diabetes and heart disease may elevate the risk of cardiac toxicity in elderly breast cancer patients who were on trastuzumab treatment, a study in the Annals of Oncology found. The findings underscore the importance of intensive observation for early signs of the condition and cardiac function in patients, experts said.

Related Summaries